The National Center for Toxicological Research (NCTR), FDA's internationally recognized research center, plays a critical role in the FDA’s mission. NCTR—in partnership with researchers from elsewhere in FDA, other government agencies, academia, and industry—provides innovative technology, methods development, vital scientific training, and technical expertise. The unique scientific expertise of NCTR is critical in supporting FDA product centers and their regulatory roles. 

Purpose

The Science Advisory Board (SAB) to NCTR advises the NCTR Director in establishing, implementing, and evaluating the research programs that assist the FDA Commissioner in fulfilling his regulatory responsibilities. The Board provides an extra-agency review in ensuring that the research programs at NCTR are scientifically sound and pertinent. The SAB consists of a core of nine members including the Chair. Members and the Chair are selected by the FDA Commissioner or designee from among leading authorities in the fields related to toxicological research. The core of voting members may include one technically qualified member, selected by the Commissioner or designee, who is identified with consumer interests and is recommended by either a consortium of consumer-oriented organizations or other interested persons.

Board Membership

The Committee shall consist of a core of nine voting members including the Chair. Members and the Chair are selected by the Commissioner or designee from among authorities knowledgeable in the fields of toxicological research. Members will be invited to serve for overlapping terms of up to four years. Almost all non-Federal members of this committee serve as Special Government Employees. The core of voting members may include one technically qualified member, selected by the Commissioner or designee, who is identified with consumer interests and is recommended by either a consortium of consumer-oriented organizations or other interested persons.